vs
爱德华生命科学（EW）与Rithm Capital Corp.（RITM）财务数据对比。点击上方公司名可切换其他公司
爱德华生命科学的季度营收约是Rithm Capital Corp.的2.0倍（$1.6B vs $828.2M），爱德华生命科学净利率更高（23.1% vs 13.2%，领先9.9%），Rithm Capital Corp.同比增速更快（508.5% vs 16.7%），过去两年爱德华生命科学的营收复合增速更高（9.7% vs -17.9%）
爱德华生命科学是总部位于美国加利福尼亚州尔湾的医疗科技企业，专注于人工心脏瓣膜及血流动力学监测领域，其研发的Sapien经导管主动脉心脏瓣膜采用牛组织材质，搭配球囊扩张式钴铬合金支架，可通过导管完成植入。
Rithm Capital Corp.是总部位于美国纽约的投资管理机构，核心业务聚焦房地产投资与另类资产投资，依托专业的投研团队和成熟的市场运营经验，为合作伙伴及投资者提供优质的资产配置解决方案与长期收益回报。
EW vs RITM — 直观对比
营收规模更大
EW
是对方的2.0倍
$828.2M
营收增速更快
RITM
高出491.8%
16.7%
净利率更高
EW
高出9.9%
13.2%
两年增速更快
EW
近两年复合增速
-17.9%
损益表 — Q1 FY2026 vs Q1 FY2026
| 指标 | | |
|---|---|---|
| 营收 | $1.6B | $828.2M |
| 净利润 | $380.7M | $109.5M |
| 毛利率 | 78.0% | — |
| 营业利润率 | 1.8% | 29.9% |
| 净利率 | 23.1% | 13.2% |
| 营收同比 | 16.7% | 508.5% |
| 净利润同比 | 6.8% | 27.7% |
| 每股收益（稀释后） | $0.66 | $0.12 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收EWRITM
| Q1 26 | $1.6B | $828.2M | ||
| Q4 25 | $1.6B | $1.5B | ||
| Q3 25 | $1.6B | $1.1B | ||
| Q2 25 | $1.5B | $1.2B | ||
| Q1 25 | $1.4B | $768.4M | ||
| Q4 24 | $1.4B | $2.1B | ||
| Q3 24 | $1.4B | $619.5M | ||
| Q2 24 | $1.4B | $1.2B |
净利润EWRITM
| Q1 26 | $380.7M | $109.5M | ||
| Q4 25 | $91.2M | $85.0M | ||
| Q3 25 | $291.1M | $221.5M | ||
| Q2 25 | $333.2M | $311.7M | ||
| Q1 25 | $358.0M | $78.8M | ||
| Q4 24 | $385.6M | $290.2M | ||
| Q3 24 | $3.1B | $121.7M | ||
| Q2 24 | $366.3M | $235.6M |
毛利率EWRITM
| Q1 26 | 78.0% | — | ||
| Q4 25 | 78.1% | — | ||
| Q3 25 | 77.8% | — | ||
| Q2 25 | 77.5% | — | ||
| Q1 25 | 78.7% | — | ||
| Q4 24 | 78.9% | — | ||
| Q3 24 | 80.6% | — | ||
| Q2 24 | 79.9% | — |
营业利润率EWRITM
| Q1 26 | 1.8% | 29.9% | ||
| Q4 25 | 9.6% | 13.8% | ||
| Q3 25 | 19.8% | 21.4% | ||
| Q2 25 | 26.8% | 25.2% | ||
| Q1 25 | 27.9% | 7.4% | ||
| Q4 24 | 22.6% | 23.8% | ||
| Q3 24 | 25.9% | 7.3% | ||
| Q2 24 | 26.8% | 23.6% |
净利率EWRITM
| Q1 26 | 23.1% | 13.2% | ||
| Q4 25 | 5.8% | 5.7% | ||
| Q3 25 | 18.7% | 20.0% | ||
| Q2 25 | 21.7% | 25.6% | ||
| Q1 25 | 25.3% | 10.3% | ||
| Q4 24 | 27.8% | 14.0% | ||
| Q3 24 | 226.7% | 19.7% | ||
| Q2 24 | 26.7% | 19.2% |
每股收益（稀释后）EWRITM
| Q1 26 | $0.66 | $0.12 | ||
| Q4 25 | $0.16 | $0.09 | ||
| Q3 25 | $0.50 | $0.35 | ||
| Q2 25 | $0.56 | $0.53 | ||
| Q1 25 | $0.61 | $0.07 | ||
| Q4 24 | $0.65 | $0.50 | ||
| Q3 24 | $5.13 | $0.20 | ||
| Q2 24 | $0.61 | $0.43 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | — | — |
| 总债务越低越好 | — | — |
| 股东权益账面价值 | — | $9.1B |
| 总资产 | — | $53.4B |
| 负债/权益比越低杠杆越低 | — | — |
8季度趋势，按日历期对齐
现金及短期投资EWRITM
| Q1 26 | — | — | ||
| Q4 25 | $4.2B | $1.8B | ||
| Q3 25 | $3.8B | $1.6B | ||
| Q2 25 | $4.1B | $1.6B | ||
| Q1 25 | $3.9B | $1.5B | ||
| Q4 24 | $4.0B | $1.5B | ||
| Q3 24 | $4.4B | $1.6B | ||
| Q2 24 | $2.0B | $1.2B |
总债务EWRITM
| Q1 26 | — | — | ||
| Q4 25 | — | $35.4B | ||
| Q3 25 | — | $32.2B | ||
| Q2 25 | — | $31.2B | ||
| Q1 25 | — | $32.2B | ||
| Q4 24 | — | $32.6B | ||
| Q3 24 | — | $29.6B | ||
| Q2 24 | — | $30.1B |
股东权益EWRITM
| Q1 26 | — | $9.1B | ||
| Q4 25 | $10.3B | $8.4B | ||
| Q3 25 | $10.2B | $8.5B | ||
| Q2 25 | $10.5B | $7.9B | ||
| Q1 25 | $10.1B | $7.8B | ||
| Q4 24 | $10.0B | $7.8B | ||
| Q3 24 | $9.5B | $7.7B | ||
| Q2 24 | $7.4B | $7.3B |
总资产EWRITM
| Q1 26 | — | $53.4B | ||
| Q4 25 | $13.7B | $53.1B | ||
| Q3 25 | $13.3B | $47.2B | ||
| Q2 25 | $13.5B | $44.3B | ||
| Q1 25 | $13.0B | $45.3B | ||
| Q4 24 | $13.1B | $46.0B | ||
| Q3 24 | $13.0B | $42.3B | ||
| Q2 24 | $10.1B | $42.0B |
负债/权益比EWRITM
| Q1 26 | — | — | ||
| Q4 25 | — | 4.20× | ||
| Q3 25 | — | 3.79× | ||
| Q2 25 | — | 3.92× | ||
| Q1 25 | — | 4.14× | ||
| Q4 24 | — | 4.18× | ||
| Q3 24 | — | 3.87× | ||
| Q2 24 | — | 4.10× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
EW
暂无分部数据
RITM
| Servicing revenue, net | $375.1M | 45% |
| Other | $234.9M | 28% |
| Gain on originated residential mortgage loans, held-for-sale, net | $195.0M | 24% |
| Other revenue | $23.3M | 3% |
